Short Interest in Apogee Therapeutics, Inc. (NASDAQ:APGE) Declines By 5.2%

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) saw a large decrease in short interest in February. As of February 29th, there was short interest totalling 3,130,000 shares, a decrease of 5.2% from the February 14th total of 3,300,000 shares. Currently, 14.6% of the company’s stock are short sold. Based on an average daily volume […]

Leave a Reply

Your email address will not be published.

Previous post Zacks Research Analysts Decrease Earnings Estimates for LKQ Co. (NASDAQ:LKQ)
Next post Q3 2024 EPS Estimates for AngioDynamics, Inc. Reduced by Zacks Research (NASDAQ:ANGO)